LivaNova is a global medical technology company that develops and manufactures innovative therapeutic solutions for patients with chronic and acute conditions. The company operates in two business units: Cardiac Surgery and Neuromodulation. LivaNova's products include heart-lung machines, oxygenators, autotransfusion systems, and neuromodulation devices. The company was formed in 2015 through the merger of Sorin Group and Cyberonics. LivaNova is headquartered in London, UK, and has operations in more than 100 countries.